These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 19403015)
41. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin. Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595 [TBL] [Abstract][Full Text] [Related]
42. [Prospect of liver fibrosis]. Jia JD Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):5-6. PubMed ID: 19391279 [No Abstract] [Full Text] [Related]
43. [Serologic diagnosis of liver fibrosis]. Sauerbruch T Dtsch Med Wochenschr; 1999 Oct; 124(41):1191. PubMed ID: 10572514 [No Abstract] [Full Text] [Related]
44. A meta-analysis of transient elastography for the detection of hepatic fibrosis. Stebbing J; Farouk L; Panos G; Anderson M; Jiao LR; Mandalia S; Bower M; Gazzard B; Nelson M J Clin Gastroenterol; 2010 Mar; 44(3):214-9. PubMed ID: 19745758 [TBL] [Abstract][Full Text] [Related]
45. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661 [TBL] [Abstract][Full Text] [Related]
46. [The diagnosis and treatment of cirrhoses of the liver in children]. Purachev AG; Generalov AG; Malinina LI; Chistova LV; Ryzhkova LA; Leont'ev AF; Osipov IuN Vopr Okhr Materin Det; 1967 Jun; 12(7):3-7. PubMed ID: 5629286 [No Abstract] [Full Text] [Related]
47. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines? Castera L; Denis J; Babany G; Roudot-Thoraval F J Hepatol; 2007 Mar; 46(3):528-9; author reply 529-30. PubMed ID: 17239479 [No Abstract] [Full Text] [Related]
50. Antifibrotic effect of angiotensin blockers in hypertensive hepatitis C patients. Bahde R; Kapoor S Liver Int; 2009 Nov; 29(10):1597; author reply 1598. PubMed ID: 19744164 [No Abstract] [Full Text] [Related]
51. Cirrhosis of the liver. Thomson AD Practitioner; 1981 Apr; 225(1354):449-59. PubMed ID: 7279835 [No Abstract] [Full Text] [Related]
52. Management of cirrhosis due to chronic hepatitis C. Everson GT J Hepatol; 2005; 42 Suppl(1):S65-74. PubMed ID: 15777574 [No Abstract] [Full Text] [Related]
53. [Should we treat cirrhosis in hepatitis C carriers with antiviral agents?]. Brenard R; Closon ML; Fevery J; Hautekeete M Rev Med Brux; 1999 Feb; 20(1):A50. PubMed ID: 10091538 [No Abstract] [Full Text] [Related]
54. Non-invasive assessment of liver fibrosis: are we ready? Castera L; Pinzani M Lancet; 2010 Apr; 375(9724):1419-20. PubMed ID: 20417845 [No Abstract] [Full Text] [Related]
55. [Liver cirrhosis and the most common complications: diagnosis and treatment]. Gross M MMW Fortschr Med; 2015 Mar; 157 Suppl 1():75-9. PubMed ID: 26012993 [No Abstract] [Full Text] [Related]
56. The ELF panel: a new crystal ball in hepatology? Pinzani M Gut; 2010 Sep; 59(9):1165-7. PubMed ID: 20587543 [No Abstract] [Full Text] [Related]